LifeCell gets grant to develop bi-layered human skin
This article was originally published in Clinica
LifeCell has received a $300,000 grant from the National Science Foundation to develop a composite, bi-layered human skin product. In a two-year programme, the company intends to combine human keratinocytes on the surface of its human dermal tissue graft, AlloDerm.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.